|
HE 1.75:OEI-12-89-00194
|
DRG 121 validation study update : circulatory disorders with myocardial infarction and cardiovascular complications |
1 |
|
HE 1.75:OEI-12-89-00195
|
DRG 296 validation update : nutritional and miscellaneous metabolic disorders |
1 |
|
HE 1.75:OEI-12-89-00196
|
DRG 154 validation update : stomach, esophageal, and duodenal procedures |
1 |
|
HE 1.75:OEI-12-89-89220
|
Interstate flow of Medicare funds |
1 |
|
HE 1.75:OEI-12-90-00530
|
Controls over authorized agents : National Practitioner Data Bank : management advisory report |
1 |
|
HE 1.75:OEI-12-90-00660
|
FY 1985 national DRG validation study : peer review organization coding accuracy |
1 |
|
HE 1.75:OEI-12-90-00770
|
Perspectives of drug manufacturers : abbreviated new drug applications |
1 |
|
HE 1.75:OEI-12-90-00771
|
Perspectives of drug manufacturers : investigational new drug and new drug applications |
1 |
|
HE 1.75:OEI-12-90-00800
|
Strategies to reduce Medicaid drug expenditures |
1 |
|
HE 1.75:OEI-12-90-01000
|
Hospital reporting of adverse drug reactions |
1 |
|
HE 1.75:OEI-12-90-01060
|
Hotline referral follow-up |
1 |
|
HE 1.75:OEI-12-90-02020
|
Implementing user fees in the Food and Drug Administration : a case study |
1 |
|
HE 1.75:OEI-12-90-02450
|
Effects of hospital mergers on costs, revenues, and patient volume |
1 |
|
HE 1.75:OEI-12-91-00490
|
Multiple copy prescription programs : state experiences |
1 |
|
HE 1.75:OEI-12-91-01380
|
Performance indicators in the JOBS program |
1 |
|
HE 1.75:OEI-12-91-01410
|
Electronic media claims and contractors' for-profit subsidiaries : a management advisory report |
1 |
|
HE 1.75:OEI-12-91-01420
|
Effect of ERISA on state insurance laws : a management advisory report |
1 |
|
HE 1.75:OEI-12-91-01430
|
Healthy Difference : lessons learned about information dissemination |
1 |
|
HE 1.75:OEI-12-91-01510
|
A review of HHS children's programs |
1 |
|
HE 1.75:OEI-12-92-00200
|
OIG oversight of FDA activities : a summary report |
1 |